ResearcherActive in the last 2 years

The-Hung Dang

Verified by OpenAlex author ID (good confidence)As of 10 November 2026

Matched on OpenAlex author ID A5108982612.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells. Last author DOI 10.1177/10732748241305835 ↗
Anaplastic lymphoma kinase inhibitor NVP‑TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells. Co-author DOI 10.3892/or.2021.7979 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Hong-Quan Duong · 2 shared papers, 2021–2024
- Paper Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells. DOI 10.1177/10732748241305835 ↗
- Paper Anaplastic lymphoma kinase inhibitor NVP‑TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells. DOI 10.3892/or.2021.7979 ↗
Yeon-Sun Seong · 1 shared paper, 2021
- Paper Anaplastic lymphoma kinase inhibitor NVP‑TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells. DOI 10.3892/or.2021.7979 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.